HMG-CoA reductase inhibitors.
Illingworth
D R
DR
Division of Endocrinology, Diabetes, and Clinical Nutrition (L465), Oregon Health Sciences University, Portland, Oregon 97201, USA.
Tobert
J A
JA
D000924:Anticholesteremic Agents / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D008074:Lipoproteins / Q000097:blood; D016896:Treatment Outcome
D000924:Anticholesteremic Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008074:Lipoproteins; D002784:Cholesterol